FDA clears cardiovascular claim for J&J’s InvokanaJohnson & Johnson finally has some good news to report for its diabetes blockbuster Invokana, after the FDA Share XFDA clears cardiovascular claim for J&J’s Invokanahttps://pharmaphorum.com/news/fda-clears-cardiovascular-claim-for-jjs-invokana/
